Inhibition of MDM2 by Nilotinib Contributes to Cytotoxicity in Both Philadelphia-Positive and Negative Acute Lymphoblastic Leukemia
Author:
Publisher
Public Library of Science (PLoS)
Subject
Multidisciplinary
Reference45 articles.
1. Regulation of the c-Abl and Bcr-Abl tyrosine kinases;O Hantschel;Nat Rev Mol Cell Biol,2004
2. The molecular biology of chronic myeloid leukemia;MW Deininger;Blood,2000
3. Philadelphia chromosome-positive acute lymphoblastic leukemia: current treatment and future perspectives;HJ Lee;Cancer,2011
4. Signaling networks associated with BCR-ABL-dependent transformation;LA Hazlehurst;Cancer Control,2009
5. Transformation of hematopoietic cells by BCR/ABL requires activation of a PI-3k/Akt-dependent pathway;T Skorski;EMBO J,1997
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Serum and lymph pharmacokinetics of nilotinib delivered by yeast glucan particles per os;International Journal of Pharmaceutics;2023-03
2. Upregulation of p53 through induction of MDM2 degradation: improved potency through the introduction of an alkylketone sidechain on the anthraquinone core;Journal of Enzyme Inhibition and Medicinal Chemistry;2022-08-31
3. Kill Two Birds with One Stone: A Multifunctional Dual‐Targeting Protein Drug to Overcome Imatinib Resistance in Philadelphia Chromosome‐Positive Leukemia;Advanced Science;2022-03-03
4. It’s Getting Complicated—A Fresh Look at p53-MDM2-ARF Triangle in Tumorigenesis and Cancer Therapy;Frontiers in Cell and Developmental Biology;2022-01-26
5. The roles and regulation of MDM2 and MDMX: it is not just about p53;Genes & Development;2021-04-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3